Homocysteine and androgen profiles show outcome-specific associations in PCOS patients with infertility, live birth, or spontaneous abortion.
This retrospective cohort study included 875 patients with polycystic ovary syndrome (PCOS) stratified by reproductive outcomes: infertility (n=302), pregnancy (n=573), live birth (n=266), and spontaneous abortion (n=292). The analysis focused on associations between homocysteine (HCY) and androgen profiles across these distinct clinical groups.
Metabolic disturbances were most pronounced in the infertile patient group, followed by the spontaneous abortion group. The live birth group exhibited the most favorable metabolic profile, with all group comparisons showing statistical significance (P < 0.05). In the infertile subgroup, HCY demonstrated broad positive correlations with multiple androgens, including independent associations with total testosterone (TT), bioavailable testosterone (Bio-T), free testosterone (FT), and the free androgen index (FAI) (beta = 0.12–0.21; all P < 0.01).
In the live birth group, HCY was independently positively associated with TT (beta = 0.30; P < 0.01). Conversely, in the spontaneous abortion group, HCY was independently negatively associated with dehydroepiandrosterone (DHEA) (beta = -0.16; P = 0.02). No adverse events, serious adverse events, discontinuations, or tolerability issues were reported in the study.
The study highlights that HCY-androgen associations in PCOS are reproductive outcome-specific. These divergent patterns may inform risk stratification across different reproductive stages. However, as an observational study, causal inferences cannot be drawn. The results warrant cautious interpretation regarding clinical management strategies for PCOS patients based on reproductive history.